Vialize V1

The Next Generation Placental Membrane Allograft for Hospital Use

Vialize, a lyophilized dehydrated complete human placental membrane (dCHPM) allograft, is designed for use as a wound covering or barrier membrane. Unlike many other placental allografts that typically contain one or two layers of the placental membrane, Vialize retains all three layers of the membrane using the patented Clearify® technology.1 Vialize allografts are never delaminated allowing for optimal preservation of the 3D architecture of the native tissue.

4x thicker, 6x more growth factors, 4x more protein than the competitor graft1,2
Easy to handle and apply
Retains key structural components & proteins1

Case Reports

Watch the use of Vialize in a Myomectomy Case.

Download Case Report

The Use of a Lyophilized dCHPM Allograft for Wound Bed Preparation in a Trauma Induced Wound

A healthy 32-year-old male presented with severe left foot injury following a car accident. The wound continued to present complications six weeks after an initial first ray amputation. Lyophilized dCHPM was placed one week prior to a split thickness skin graft (STSG). Within one week the granulation tissue increased from 40% to 90% wound bed coverage, and the STSG had fully taken within 3 weeks.
view report

Surgical Repair of Complete Achilles Rupture with Placement of Lyophilized dCHPM Allograft

A 27-year-old female presented with a complete Achilles rupture and underwent surgical repair with the use of lyophilized dCHPM as a barrier membrane. After six weeks, the patient weaned out of the Achilles walking boot, progressed in therapy, and gradually returned to activities without pain.
view report

Robotic Laparoscopic Myomectomy with Placement of Lyophilized dCHPM Allograft

A 46-year-old female underwent a myomectomy with the placement of lyophilized dCHPM after being diagnosed with multiple fibroids. The lyophilized dCHPM was easily placed through the robotic port and onto the uterine surface. The patient was able to return to normal activities with routine follow up after eight weeks.
view report

Common Clinical Applications

Procedure Types*†
  • Amputations
  • Hysterectomies
  • Lumbar & Cervical Fusions
  • Myomectomies
  • Surgical Wounds
  • Tendon & Ligament Repairs
  • Traumatic Wounds
  • Ulcers
*Vialize is intended to be used as a wound covering or barrier membrane.
†Vialize complements standard of care as a barrier membrane following primary repair or closure.
  • General Surgery
  • Orthopedic Surgery
  • Plastic Surgery
  • Podiatry
  • Spine & Neurosurgery
  • Vascular Surgery

Common Anatomical Applications


Sizes & SKUs

Size 2 x 3 cm 4 x 4 cm 4 x 6 cm 6 x 8 cm 2 x 12 cm
SKU VL-2030 VL-4040 VL-4060 VL-6080 VL-0212

Sheet Format  |  Shelf-stable for up to five (5) years

Related Resources

1. Data on file.

2. Data is compared to the leading dual-layer allograft and reported as an average.

3. Nussbaum, S. R., Carter, M. J., Fife, C. E., DaVanzo, J., Haught, R., Nusgart, M., & Cartwright, D. (2018). An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research21(1), 27–32.

4. Wound Healing in Chronic Wounds. WoundSource. [Submitted 2016 Sep 29]. 9. De Silva, G. S., Saffaf, K., Sanchez, L. A., & Zayed, M. A. (2018). Amputation stump perfusion is predictive of post-operative necrotic eschar formation. American journal of surgery, 216(3), 540–546.

5. Kozub, M., Gachewicz, B., Kasprzyk, M., Roszak, M., Gasiorowski, L., & Dyszkiewicz, W. (2019). Impact of smoking history on postoperative complications after lung cancer surgery – a study based on 286 cases. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery16(1), 13–18.



© 2016-2024 Stimlabs® LLC; STIMLABS, REVITA, COGENEX, ENVERSE, VIALIZE, RELESE, and CLEARIFY are registered trademarks of Stimlabs LLC. 

Join our mailing list

This field is for validation purposes and should be left unchanged.